Predictive value of ERCC1, ERCC2, and XRCC1 overexpression for stage III colorectal cancer patients receiving FOLFOX-4 adjuvant chemotherapy (Q43452895)

From Wikidata

Jump to navigation Jump to search

scientific article published on 31 August 2013

Language	Label	Description	Also known as
English	Predictive value of ERCC1, ERCC2, and XRCC1 overexpression for stage III colorectal cancer patients receiving FOLFOX-4 adjuvant chemotherapy	scientific article published on 31 August 2013

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Predictive value of ERCC1, ERCC2, and XRCC1 overexpression for stage III colorectal cancer patients receiving FOLFOX-4 adjuvant chemotherapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

colorectal cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

colorectal carcinoma

1 reference

based on heuristic

inferred from title

author name string

Ming-Yii Huang

1

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Hsiang-Lin Tsai

2

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Chih-Hung Lin

3

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Ching-Wen Huang

4

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Cheng-Jen Ma

5

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Chun-Ming Huang

6

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Chee-Yin Chai

7

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Jaw-Yuan Wang

8

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

31 August 2013

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Journal of Surgical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

108

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

457-464

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Socioeconomic position and participation in colorectal cancer screening

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23422

21 January 2018

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23422

21 January 2018

Standard postoperative monitoring of patients after primary resection of colon and rectum cancer

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23422

21 January 2018

EGF61A>G polymorphism as predictive marker of clinical outcome to first-line capecitabine and oxaliplatin in metastatic colorectal cancer.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23422

21 January 2018

Mechanisms controlling sensitivity to platinum complexes: role of p53 and DNA mismatch repair.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23422

21 January 2018

DNA excision repair

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23422

21 January 2018

Nucleotide excision repair: from E. coli to man.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23422

21 January 2018

ABCC5, ERCC2, XPA and XRCC1 transcript abundance levels correlate with cisplatin chemoresistance in non-small cell lung cancer cell lines

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23422

21 January 2018

Multiple genetic polymorphisms in the prediction of clinical outcome of metastatic colorectal cancer patients treated with first-line FOLFOX-4 chemotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23422

21 January 2018

Platinum-DNA adduct, nucleotide excision repair and platinum based anti-cancer chemotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23422

21 January 2018

Increased nucleotide excision repair in cisplatin-resistant ovarian cancer cells: role of ERCC1-XPF.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23422

21 January 2018

ERCC1 and ERCC2 expression in malignant tissues from ovarian cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23422

21 January 2018

Small interfering RNA-induced suppression of ERCC1 enhances sensitivity of human cancer cells to cisplatin.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23422

21 January 2018

ERCC1 and clinical resistance to platinum-based therapy

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23422

21 January 2018

Colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23422

21 January 2018

Should Dukes' B patients receive adjuvant therapy? A statistical perspective

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23422

21 January 2018

ERCC2 2251A>C genetic polymorphism was highly correlated with early relapse in high-risk stage II and stage III colorectal cancer patients: a preliminary study

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23422

21 January 2018

The preoperative assessment and postoperative surveillance of patients with colon and rectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23422

21 January 2018

Pharmacogenetic predictors of adverse events and response to chemotherapy in metastatic colorectal cancer: results from North American Gastrointestinal Intergroup Trial N9741.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23422

21 January 2018

Circulating tumor cells as a surrogate marker for determining clinical outcome to mFOLFOX chemotherapy in patients with stage III colon cancer

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23422

21 January 2018

Systemic therapy for metastatic colorectal cancer: current options, current evidence

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23422

21 January 2018

Oxaliplatin: a review of preclinical and clinical studies.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23422

21 January 2018

Platinum resistance related to a functional NER pathway

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23422

21 January 2018

Current status of excision repair cross complementing-group 1 (ERCC1) in cancer.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23422

21 January 2018

Prognostic value of ERCC1, thymidylate synthase, and glutathione S-transferase pi for 5-FU/oxaliplatin chemotherapy in advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23422

21 January 2018

Quantitative real-time RT-PCR for detection of disseminated tumor cells in peripheral blood of patients with colorectal cancer using different mRNA markers.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23422

21 January 2018

Very low prevalence of XPD K751Q polymorphism and its association with XPD expression and outcomes of FOLFOX-4 treatment in Asian patients with colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23422

21 January 2018

The base excision repair: mechanisms and its relevance for cancer susceptibility

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23422

21 January 2018

Biodegradable Chitosan-Based Ambroxol Hydrochloride Microspheres: Effect of Cross-Linking Agents

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23422

21 January 2018

Prognostic and predictive role of JWA and XRCC1 expressions in gastric cancer

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23422

21 January 2018

High XRCC1 protein expression is associated with poorer survival in patients with head and neck squamous cell carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23422

21 January 2018

Persistent high postoperative carcinoembryonic antigen in colorectal cancer patients--is it important?

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23422

21 January 2018

Identifiers

10.1002/JSO.23422

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43452895&oldid=1989089225"